ARNT2 and breast cancer: For example, researchers suggested that ARNT2 may be a direct target of p53, which allows tumor angiogenesis [7]; Qin et al. found that ARNT2 can act through metabolism regulated by hypoxia-inducible factor-1 to affect the progression of breast cancer [8].